Novel therapies for relapsed/refractory multiple myeloma: how can we improve on "salvage" therapy?--introduction.
Novel therapies for relapsed/refractory multiple myeloma: how can we improve on "salvage" therapy?--introduction. Semin Hematol. 2012 Jul; 49 Suppl 1:S1-2.